NCT05366647

Brief Summary

Study aims to compare the effectiveness and safety profile of Gonioscopy-assisted Transluminal Trabeculotomy and canaloplasty, in order to find out if one operation is superior to the other. Both procedures are performed in patients with medically uncontrolled open-angle glaucoma. Canaloplasty is a recently newly introduced procedure, which showed encouraging results without antimetabolite usage intra- and postoperatively. Gonioscopy-assisted Transluminal Trabeculotomy is the procedure that aims the same mechanism of aqueous outflow, however is perform with ab interno approach, which comprise it to the minimally invasive glaucoma surgery techniques. Purpose of the study is to compare both surgeries concerning success rate, intraocular pressure, medication burden and complications rate. So far there is no comparison of the Gonioscopy-assisted Transluminal Trabeculotomy and canaloplasty available.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 4, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 9, 2022

Completed
23 days until next milestone

Study Start

First participant enrolled

June 1, 2022

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

March 7, 2025

Status Verified

May 1, 2024

Enrollment Period

3 years

First QC Date

May 4, 2022

Last Update Submit

March 4, 2025

Conditions

Keywords

Gonioscopy-assisted Transluminal TrabeculotomyCanaloplastyGlaucoma

Outcome Measures

Primary Outcomes (2)

  • success rate (complete and qualified success)

    Success is defined: 1. IOP \< 21 mmHg and at least 20% IOP change from baseline 2. IOP \< 18 mmHg

    12 months

  • success rate (complete and qualified success)

    Success is defined: 1. IOP \< 21 mmHg and at least 20% IOP change from baseline 2. IOP \< 18 mmHg

    24 months

Secondary Outcomes (2)

  • IOP, medication, complications

    12 months

  • IOP, medication, complications

    24 months

Study Arms (2)

Canaloplasty

ACTIVE COMPARATOR

Canaloplasty ab externo

Procedure: Gonioscopy-assisted Transluminal Trabeculotomy

Gonioscopy-assisted Transluminal Trabeculotomy

ACTIVE COMPARATOR

Gonioscopy-assisted Transluminal Trabeculotomy ab interno

Procedure: canaloplasty

Interventions

canaloplastyPROCEDURE

canaloplasty ab interno with tensioning suture

Gonioscopy-assisted Transluminal Trabeculotomy

Gonioscopy-assisted Transluminal Trabeculotomy ab interno

Canaloplasty

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Years and older (Adult, Older Adult)
  • patients with confirmed uncontrolled open angle glaucoma
  • no prior glaucoma surgery (once laser trabeculoplasty or cyclophotocoagulation) allowed

You may not qualify if:

  • angle closure glaucoma
  • congenital glaucoma
  • inflammatory glaucoma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ophthalmology Clinic Medical University of Bialystok

Bialystok, 15-089, Poland

RECRUITING

MeSH Terms

Conditions

Glaucoma, Open-AngleGlaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Study Officials

  • Joanna Konopińska

    Medical University of Bialystok, Poland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Joanna Konopińska

CONTACT

Ewa Kosior-Jarecka

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Ophthalomogy, Principal Investigator, Clinical Professor

Study Record Dates

First Submitted

May 4, 2022

First Posted

May 9, 2022

Study Start

June 1, 2022

Primary Completion

June 1, 2025

Study Completion

June 1, 2025

Last Updated

March 7, 2025

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

All materials and information are available upon an e-mail request on principal investigator

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
5 years

Locations